SPTLC1

SPTLC1 Protein

Score: 0.489 Price: $0.43 Medium Druggability Status: active
HYPOTHESES
1
PAPERS
6
KG EDGES
0
DEBATES
0

3D Protein Structure

🧬 SPTLC1 — PDB 4HWL Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Medium
Score: 0.50
Clinical Stage
Phase I
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:
neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: APOE-Mediated Synaptic Lipid Raft Stabilization
Known Drugs:
No known drugs targeting this protein
Structural Data:

🧬 3D Protein Structure

🧬 SPTLC1 — PDB 4HWL Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Linked Hypotheses (1)

APOE-Mediated Synaptic Lipid Raft Stabilization0.426

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.50 (20%) Evidence 0.54 (20%) Safety 0.50 (15%) Competitive 0.80 (10%) Connectivity 0.00 (10%) 0.489 composite

Knowledge Graph (20)

activates (2)

SPTLC1 SPTLC2
SPTLC1 Pyramidal

associated with (5)

SPTLC1 Amyotrophic lateral sclerosis
SPTLC1 Juvenile amyotrophic lateral sclerosis
SPTLC1 neurodegeneration
SPTLC1 RAB7
SPTLC1 NGFR

co discussed (6)

SPTLC1 TREM2
SPTLC1 ULK1
SPTLC1 MTOR
SPTLC1 TFEB
SPTLC1 HSPA1A
...and 1 more

expressed in (2)

SPTLC1 KCNJ6
SPTLC1 STRAP

inhibits (1)

SPTLC1 ABCA1

interacts with (1)

SPTLC1 ORMDL proteins

involved in (2)

SPTLC1 Sphingolipid biosynthesis
SPTLC1 1-Deoxysphingolipids

regulates (1)

SPTLC1 Sphingolipid metabolism

Debate History (0)

No debates yet